Cargando…
Public Risk-Taking and Rewards During the COVID-19 Pandemic - A Case Study of Remdesivir in the Context of Global Health Equity
Public investment, through both research grants and university funding, plays a crucial role in the research and development (R&D) of novel health technologies, including diagnostics, therapies, and vaccines, to address the coronavirus disease 2019 (COVID-19) pandemic. Using the example of remde...
Autores principales: | Wimmer, Sabrina, Keestra, Sarai M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309932/ https://www.ncbi.nlm.nih.gov/pubmed/32945638 http://dx.doi.org/10.34172/ijhpm.2020.166 |
Ejemplares similares
-
Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register
por: Mirjam Keestra, Sarai, et al.
Publicado: (2022) -
Suicide in the context of infodemic during COVID-19 pandemic: A global perspective
por: Shoib, Sheikh, et al.
Publicado: (2022) -
Compassionate use of remdesivir in children with COVID-19
por: Méndez-Echevarría, Ana, et al.
Publicado: (2020) -
Mentorship, equity, and research productivity: lessons from a pandemic
por: Nocco, Mallika A., et al.
Publicado: (2021) -
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)